HPS Pharmacies wish to advise that Mundipharma is experiencing a supply interruption for Folotyn® vials as follows:
Folotyn® Vials
Pralatrexate 20 mg/1 mL
ARTG 192493
This supply interruption is expected to resolve in early November 2026.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that S19A products have a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Mundipharma on 1800 188 009, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates
